A novel CRISPR–Cas12a-based fluorescence anisotropy method with a high signal-to-background ratio for sensitive biosensing
Chemical Communications · 2025
DOI: 10.1039/d5cc01565k ↗At a glance
Journal article in Chemical Communications, 2025. Written by Yu Qin and 6 co-authors. Institution: College of Chemistry and Chemical Engineering, Southwest University, 400715, Chongqing, P. R. China. zsj@swu.edu.cn. Major MEDLINE topics: Biosensing Techniques, Fluorescence Polarization, CRISPR-Cas Systems, DNA, Viral. Cited 3 times so far (Crossref); 38 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Herein, a novel CRISPR–Cas12a-based fluorescence anisotropy method with a high signal-to-background ratio was designed for sensitive biosensing.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- College of Chemistry and Chemical Engineering, Southwest University, 400715, Chongqing, P. R. China. zsj@swu.edu.cn.
- Key Laboratory of Biomedical Analytics, Chongqing Science and Technology Bureau, College of Pharmaceutical Sciences, Southwest University, 400715, Chongqing, P. R. China. zhy2013@swu.edu.cn.
Funding
- National Natural Science Foundation of China
Cite
APA
Qin, Y., Xie, J. L., Mao, K., Li, Y. F., Huang, C. Z., Zou, H. Y., & Zhen, S. J. (2025). A novel CRISPR–Cas12a-based fluorescence anisotropy method with a high signal-to-background ratio for sensitive biosensing. Chemical Communications. https://doi.org/10.1039/d5cc01565k
Vancouver
Qin Y, Xie JL, Mao K, Li YF, Huang CZ, Zou HY, et al. A novel CRISPR–Cas12a-based fluorescence anisotropy method with a high signal-to-background ratio for sensitive biosensing. Chemical Communications. 2025. doi:10.1039/d5cc01565k
BibTeX
@article{Qin2025,
author = {Qin, Yu and Xie, Jia Li and Mao, Kai and Li, Yuan Fang and Huang, Cheng Zhi and Zou, Hong Yan and Zhen, Shu Jun},
title = {A novel CRISPR–Cas12a-based fluorescence anisotropy method with a high signal-to-background ratio for sensitive biosensing},
journal = {Chemical Communications},
year = {2025},
doi = {10.1039/d5cc01565k}
}
EUVIMED